153 A Retrospective Review of the Incidence and Management of Toxicities arising during Lorlatinib Treatment for Metastatic ALK gene fusion Non-Small Cell Lung Cancer (NSCLC) – Our Experience in a Mutationdriven Lung Cancer Clinic at The Clatterbridge Cancer Centre (CCC)

View at publisher
Authors: Kyaw Zin Oo, Helen Wong, Carles Escriu, Jonathan Heseltine
Cited by: 0
References: 1

Fields of Study & Subjects

Lung Cancer Treatments and Mutations Lung Cancer Diagnosis and Treatment Lung Cancer Research Studies

Publication details

Journal / source
Lung Cancer
Volume
212
Pages
109101–109101
Publication date
1 February 2026
Language
EN